Vercauteren S, DT Starczynowski, S Sung, K McNeil, C Salski, C-L Jensen, W Lam, A Karsan. T cells of patients with Myelodysplastic syndrome are frequently derived from the malignant clone. British Journal of Haematology. Epub. 2011.
Starczynowski DT, WL Lockwood, S Delehouzee, S Lam, M-S Tsao, AF Gazdar, W Lam, and A Karsan. TRAF6 is an amplified oncogene bridging the Ras and nuclear factor-kB cascade in lung cancer. Journal of Clinical Investigation. Oct;121(10):4095-105. 2011.
Rhyasen G and DT Starczynowski. Deregulation of microRNAs in Myelodysplastic Syndromes. Leukemia. Jan;26(1):13-22. 2011.
Kuchenbauer F, SM Mah, M Heuser, A McPherson, J Ruschmann, A Rouhi, T Berg, L Bullinger, B Argiropoulos, RD Morin, D. Lai, DT Starczynowski, A Karsan, CJ Eaves, A Watahiki, Y Wang, SA Aparicio, A Ganser, J Krauter, H Doehner, K Doehner, MA Marra, FD Carmargo L Palmquist, C Buske, and RK Humphries. Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells. Blood. Sep 22;118(12):3350-8. 2011.
Starczynowski DT, F Kuchenbauer, J Wegrzyn, K Humphries, and A Karsan. Increased expression of microRNA-146 disrupts differentiation and survival of hematopoietic progenitor cells. Experimental Hematology. Feb;39(2):167-178.e4. 2011.
Starczynowski DT, RD Morin, A McPherson, J Lam, R Chari, J Wegrzyn, A Delaney, AL Prabhu, Y Zhao, M Hirst, W Lam, MA Marra, and A Karsan. Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. Blood. 2011.
Starczynowski DT, S Vercauteren, S Sung, A Brooks-Wilson, J Spinelli, C Eaves, A Eaves, D Horsman, W Lam, and A Karsan. Evidence of somatic alterations of genomic copy number variants in clonally derived cells from patients with low-risk myelodysplastic syndromes. Leukemia Research. Apr;35(4):444-7. 2011.
Vercauteren SM, S Sung, DT Starczynowski, WL Lam, H Bruyere, DE Horsman, P Tsang, H Leitch, and A Karsan. Cryptic alterations detected by array comparative genomic hybridization in bone marrow CD34+ cells are not present in peripheral blood granulocytes of patients with myelodysplastic syndrome. American Journal of Clinical Pathology, 134(1):119-126. 2010.
Starczynowski DT and A Karsan. Innate immune signaling in Myelodysplastic Syndromes. Hematology/Oncology Clinics of North America, 24(2):343-359. 2010.
Starczynowski DT and A Karsan. Deregulation of innate immune signaling in myelodysplastic syndromes is associated with deletion of chromosome arm 5q. Cell Cycle. Mar 1;9(5):855-6. 2010.
Starczynowski DT, F Kuchenbauer, B Argiropoulos, S Sung, R Morin, A Muranyi, D Hogue, R Wells, M Marra, WL Lam, K Humphries, and A Karsan. Identification of miR-145 and miR-146a as microRNAs involved in the pathogenesis of 5q- syndrome. Nature Medicine, 16(1): 49-58. 2010.
Starczynowski DT, S Vercauteren, S Sung, A Brooks-Wilson, J Spinelli, C Eaves, A Eaves, D Horsman, W Lam, and A Karsan.
High-resolution array comparative genomic hybridization of CD34+ cells from patients with low-risk myelodysplastic syndromes predicts overall and leukemia-free survival
. Blood. Oct 15;112(8):3412-24. 2008.